for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Vectura Group Signs Global Licence And Development Agreement With Aerami Therapeutics

June 8 (Reuters) - Vectura Group Plc:

* VECTURA GROUP PLC - SIGNING OF A GLOBAL LICENCE AND DEVELOPMENT AGREEMENT WITH AERAMI THERAPEUTICS

* VECTURA GROUP PLC - AGREEMENT TO SUPPORT DEVELOPMENT OF INHALED IMATINIB (VR325) FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

* VECTURA GROUP PLC - AERAMI WILL BE RESPONSIBLE FOR OVERALL DEVELOPMENT AND COMMERCIALISATION OF INHALED IMATINIB

* VECTURA GROUP - VECTURA PROVIDING DEVELOPMENT SERVICES EXPERTISE, LICENSE TO ITS FOX MESH NEBULISER TECHNOLOGY Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up